Objective: The objectives were to investigate and compare the risks and incidences of
venous thromboembolism (VTE) between the 2 groups of patients with coronavirus disease …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …

Venous thromboembolism (VTE) is common in patients with coronavirus disease-2019
(COVID-19). However, limited data exist on patient characteristics, treatments, and …

Although COVID-19 has been reported to be associated with high rates of venous
thromboembolism (VTE), the risk of VTE and bleeding after hospitalization for COVID-19 …

Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …